Society for Cardiovascular Angiography and Interventions
Lessons learned from new trials of prasugrel in patients with ACS
SAN DIEGO — Efficacy is established in randomized clinical trials. Effectiveness, however, is established in registry and/or nonrandomized observational data. The PROMETHEUS and TRIAGE studies, both presented as late-breaking clinical trials at the Society for Cardiovascular Angiography and Interventions Scientific Sessions, were attempts to establish effectiveness of prasugrel (Effient, Daiichi Sankyo/Eli Lilly).
VIDEO: Cilostazol ‘compelling’ as bridging therapy for high-risk patients to discontinue DAPT before surgery
SAN DIEGO — In this video, Charles Laham, MD, FSCAI, an interventional cardiologist at Holy Family Memorial Hospital in Wisconsin, discusses results of the OUTSIDE START trial, which he presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
TRIAGE: Risk algorithm identifies patients who may benefit from intensive antiplatelet therapy
SAN DIEGO — A risk-assessment algorithm that incorporates clinical risk factors and platelet function testing may help to identify patients who might benefit from intensive antiplatelet therapy after PCI, according to results from the TRIAGE study.
An in-depth look at the ORBIT II trial
SAN DIEGO — Previous studies have shown that a high load of calcium in coronary arteries predicts an increased rate of major adverse cardiac events.
MILLION: Combined BP, cholesterol lowering reduces coronary plaque volume
SAN DIEGO — Among patients with CAD, an aggressive or standard approach of combined BP and cholesterol lowering after successful PCI resulted in similar reductions in coronary plaque volume, according to results of the MILLION study presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Clinical profile of ACS patients treated with prasugrel, clopidogrel varies in US
SAN DIEGO — The clinical profile of patients with ACS treated with prasugrel as compared with clopidogrel differs substantially across U.S. academic medical centers, according to real-world data from the PROMETHEUS study.
IABP may improve mortality among patients with cardiogenic shock unable to undergo timely PCI
SAN DIEGO — Patients with cardiogenic shock after STEMI who were unable to receive timely PCI had a better rate of in-hospital mortality when treated with an intra-aortic balloon pump compared with no mechanical circulatory support, according to data presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
The new frontier: Interventional cardiology and technology
SAN DIEGO — The opening lectures at the Society for Cardiovascular Angiography and Interventions Scientific Sessions, given by Christian Assad-Kottner, MD, and Peter J. Fitzgerald, MD, PhD, felt more like TED Talks than a plenary session. This set the tone for SCAI 2015 in San Diego.
Ticagrelor more effective than clopidogrel for ad-hoc PCI
SAN DIEGO — Troponin-negative patients with ACS undergoing ad-hoc PCI had greater, more rapid reductions in platelet reactivity after treatment with ticagrelor compared with clopidogrel, according to results of a pharmacodynamics study presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
ORBIT II: Atherectomy system associated with durable long-term results, potential cost savings
SAN DIEGO — Use of an orbital atherectomy system to remove severely calcified plaque in the coronary arteries prior to stent placement resulted in low rates of major adverse cardiac events at 2 years, according to results of the ORBIT II trial presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.